The effect of endocrine therapy with medroxyprogesterone acetate, 4-hydroxyandrostenedione or tamoxifen on plasma concentrations of insulin-like growth factor (IGF)-I, IGF-II and IGFBP-1 in women with advanced breast cancer

This publication has 14 references indexed in Scilit:

• Secretion and biological actions of insulin‐like growth factor binding proteins in two human tumor‐derived cell lines in vitro
  Journal of Cellular Physiology, 1991
• Insulin-like growth factor binding protein-1 inhibits the DNA amplification induced by insulin-like growth factor I in human granulosa—luteal cells
  Human Reproduction, 1991
• Effect of Tamoxifen on Serum Insulinlike Growth Factor I Levels in Stage I Breast Cancer Patients
  JNCI Journal of the National Cancer Institute, 1990
• Insulin-like growth factor-binding protein-1 inhibits binding of IGF-I on fetal skin fibroblasts but stimulates their DNA synthesis
  Biochemical and Biophysical Research Communications, 1990
• Anti-oestrogens induce the secretion of active transforming growth factor beta from human fetal fibroblasts
  British Journal of Cancer, 1990
• Growth regulatory peptide production by human breast carcinoma cells
  Journal of Steroid Biochemistry, 1988
• Growth hormone-dependent insulin-like growth factor (IGF) binding protein both inhibits and potentiates IGF-I-stimulated DNA synthesis in human skin fibroblasts
  Biochemical and Biophysical Research Communications, 1988
• Effects of Acute High Dose and Chronic Low Dose Estrogen on Plasma Somatomedin-C and Growth in Patients with Turner’s Syndrome*
  Journal of Clinical Endocrinology & Metabolism, 1988
• Serum Somatomedin/Insulin-Like Growth Factor (IGF) and IGF Carrier Levels in Patients with Cushing's Syndrome or Receiving Glucocorticoid Therapy*
  Journal of Clinical Endocrinology & Metabolism, 1982
• Rapid endocrine effects of tamoxifen and testolactone in prostatic carcinoma patients
  The Prostate, 1982